Loading
Corteva, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest was filed 29 Nov 2023.
Corteva, Inc.: what insiders have been doing
Corteva, Inc., founded in 2018, is a Food & Beverage company based in Washington, D.C., United States. Its directors and officers file their transactions with SEC (Form 4). Between 18 October 2025 and 18 October 2026, 20 insiders published 56 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
With 56 filings in twelve months, the company is more active than the median of 19 filings across the 5,808 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 9 purchases and 4 sales. On the fundamentals side, the SEC filing (10-K) for the period ending 31 December 2025 lists revenue at 17.40 bn USD and net income at 1.09 bn USD; the dividend was 0.70 USD per share.
Over the last twelve months, not one insider purchase of Corteva, Inc. stock was filed. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4.
For comparison within the same sector, see the insider buying recorded at Village Farms International, Inc. and Orkla ASA. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
295
Thresholds
n/a
Buy Volume
€5M
9 ops. · all time
Sell Volume
€2M
4 ops. · all time
Since the insiders bought
- +21.9%Entry US$51.46 · Close at T+365 US$62.75
- +24.7%Entry US$45.78 · Close at T+365 US$57.09
- +19.6%Entry US$45.18 · Close at T+365 US$54.05
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Corteva, Inc. Buy (bullish), based on 12 analysts. Average price target: US$16.99.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 1,669 of 24,148 companies
76.8
score / 100
Value95
Quality59
FCF yld33%
Earn yld13%
EV/EBITDA3.6x
ROE4.3%
Gross mgn47%
Net mgn6.3%
Debt/EBITDA0.8x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
US$13.36
Analyst consensus
12 analystsBuy
US$13.65Target US$16.99(+27%)US$20.00
Income statement
RevenueUS$17.4B
Gross profitUS$8.2B47% margin
EBITDAUS$3.1B18% margin
Net incomeUS$1.1B2.8% margin
Valuation
PER (trailing)8.2x
PER (forward)11.8x
P/Book1.1x
Beta0.58
Balance sheet & cash
Market capUS$8.9B
Total debtUS$2.6B
Free Cash FlowUS$2.8B
Debt / Equity57%
Profitability & ownership
ROE4.3%
ROA4.5%
% insiders0.2%
% institutions92.1%
Last declaration on 5 October 2026
Declarations295 total
13,315.132 shares0Common StockSEC:0001193125-26-414664:0
11,083 shares0Common StockSEC:0001193125-26-414664:1
127,949 shares0Common StockSEC:0001193125-26-414662:0
8,517 shares@ US$81.010.0013% mcap57.4% of flowCommon StockSEC:0001193125-26-394532:0
446 shares@ US$83.390.0001% mcap100.0% of flowCommon StockSEC:0001193125-26-394539:0
412.908 shares@ US$78.710.0001% mcap100.0% of flowCommon StockSEC:0001476403-26-000010:0
412.908 shares@ US$78.710.0001% mcap4.2% of flowCommon StockSEC:0001756318-26-000007:0
98.463 shares@ US$78.710.0000% mcap3.1% of flowCommon StockSEC:0001635634-26-000006:0
2,350 shares0Common StockSEC:0001476403-26-000008:0
2,350 shares0Common StockSEC:0001756318-26-000002:0
2,350 shares0Common StockSEC:0001778544-26-000001:0
2,350 shares0Common StockSEC:0002030037-26-000002:0
2,350 shares0Common StockSEC:0001193125-26-198130:0
2,350 shares0Common StockSEC:0001635634-26-000001:0
3,870 shares0Common StockSEC:0001250570-26-000003:0
2,350 shares0Common StockSEC:0001438256-26-000001:0
2,350 shares0Common StockSEC:0001608867-26-000001:0
2,350 shares0Common StockSEC:0001770273-26-000001:0
188 shares@ US$80.1213.4% of flowCommon StockSEC:0001193125-26-085788:0
574 shares@ US$80.121.6% of flowCommon StockSEC:0001193125-26-085783:0
111 shares@ US$80.120.4% of flowCommon StockSEC:0001193125-26-085802:0
285 shares@ US$80.122.4% of flowCommon StockSEC:0001193125-26-085797:0
471 shares@ US$80.121.1% of flowCommon StockSEC:0001193125-26-085795:0
4,958 shares@ US$80.123.9% of flowCommon StockSEC:0001193125-26-085778:0
25 of 295 declarations
About Corteva, Inc.
Corteva, Inc. (NYSE: CTVA) is a United States–based agricultural company listed on the NYSE and focused on providing technology-driven solutions for farmers. Headquartered in Indianapolis, Indiana, United States, the company became an independent public company on June 1, 2019, following the separation of DowDuPont’s agriculture business. Although the current entity is relatively young, its operating heritage is much older, built on legacy seed and crop-protection platforms such as Pioneer and other long-established agricultural franchises. For investors, Corteva is best understood as a pure-play agriculture platform with direct exposure to global seed and crop-protection markets.
Corteva’s business is organized around two core segments: Seed and Crop Protection. Its seed franchise includes high-value corn, soybean, cotton and other crop genetics, trait technologies, and germplasm designed to improve yield potential, resilience and farm productivity. In Crop Protection, the company sells herbicides, fungicides, insecticides, nematicides, seed treatments and biological solutions that help farmers defend crops against weeds, pests and diseases. Corteva also offers digital farming tools and agronomic support services, which complement its physical product portfolio and strengthen customer relationships.
Read moreShow less
The company’s competitive position is supported by a balanced portfolio, a meaningful research and development engine, and a broad global footprint. Corteva emphasizes innovation, product stewardship and distribution reach as key differentiators. Its operations span major agricultural regions, including North America, Latin America, Europe and other important farming markets, giving it diversified exposure across hemispheres and crop cycles. That geographic breadth also helps reduce concentration risk tied to weather events, planting patterns or regional demand fluctuations.
Recent developments have been important for the investment case. Corteva reported strong first-quarter 2025 results and reaffirmed its full-year 2025 outlook, pointing to demand for growth platforms and continued operational discipline. Management also highlighted progress on its longer-term value framework. In addition, the company announced a plan to separate into two future public companies, a strategic move that could materially reshape the business mix and capital allocation story over time. Overall, Corteva combines cyclical agricultural exposure with structural growth drivers such as seed innovation, crop protection technology and digital agronomy, while remaining sensitive to farm economics, commodity prices, weather patterns and regulatory dynamics.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
